Good Life Advisors, LLC Eli Lilly & CO Transaction History

Good Life Advisors, LLC

$1.58 Billion
Q3 2024

A detailed history of Good Life Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Good Life Advisors, LLC holds 2,973 shares of LLY stock, worth $2.37 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,973

Previous 2,599 14.39%

Holding current value

$2.37 Million

Previous $2.35 Million 11.9%

% of portfolio

0.17%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$772.14 - $960.02 $288,780 - $359,047	374 Added 14.39%	2,973 $2.63 Million
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $186,291 - $233,623	-257 Reduced 9.0%	2,599 $2.35 Million
Q1 2024 May 02, 2024	BUY	$592.2 - $792.28 $284,256 - $380,294	480 Added 20.2%	2,856 $2.22 Million
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $300,933 - $354,761	573 Added 31.78%	2,376 $1.39 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $3,042 - $4,195	-7 Reduced 0.39%	1,803 $968,000
Q2 2023 Jul 10, 2023	BUY	$350.74 - $468.98 $38,230 - $51,118	109 Added 6.41%	1,810 $848,000
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $63,679 - $74,788	-205 Reduced 10.76%	1,701 $584,000
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $3,215 - $3,746	-10 Reduced 0.52%	1,906 $697,000
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $72,637 - $82,778	245 Added 14.66%	1,916 $619,000
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $13,657 - $16,036	-49 Reduced 2.85%	1,671 $542,000
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $34,499 - $42,874	-147 Reduced 7.87%	1,720 $493,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $51,490 - $63,900	229 Added 13.98%	1,867 $516,000
Q3 2021 Oct 29, 2021	BUY	$221.6 - $272.71 $73,571 - $90,539	332 Added 25.42%	1,638 $378,000
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $83,594 - $108,129	-463 Reduced 26.17%	1,306 $300,000
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $60,305 - $78,068	367 Added 26.18%	1,769 $329,000
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $12,915 - $17,090	-99 Reduced 6.6%	1,402 $236,000
Q3 2020 Oct 19, 2020	BUY	$146.22 - $169.13 $14,622 - $16,913	100 Added 7.14%	1,501 $221,000
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $46,792 - $56,313	-343 Reduced 19.67%	1,401 $228,000
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $14,405 - $17,829	121 Added 7.46%	1,744 $242,000
Q4 2019 Jan 17, 2020	BUY	$106.92 - $132.43 $173,531 - $214,933	1,623 New	1,623 $215,000
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $205,677 - $223,724	-1,926 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$110.79 - $129.32 $2,548 - $2,974	23 Added 1.21%	1,926 $214,000
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $211,822 - $249,331	1,903 New	1,903 $245,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Good Life Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Good Life Advisors, LLC with notifications on news.

Account

Good Life Advisors, LLC Eli Lilly & CO Transaction History